Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025 ...

Kupfer says founders have several options to help incentivize next-gen advisors. One is to offer deferred stay bonuses, where ...

Faeth Therapeutics, a clinical-stage biotechnology company advancing therapies that systematically target tumor metabolism, today announced the advancement of its lead PIKTOR regimen in endometrial ...

Superwolf became the first black-type winner for his sire, Taylor Made Stallions' freshman Instagrand, when he landed the Best of Ohio Juvenile Stakes Oct. 26 at Hollywood Gaming at Mahoning Valley ...

The Gold’s Building in downtown Lincoln reopened, starting a new phase of life for the historic building. What was once a department store is now a Hampton Inn hotel.

Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS)Prolonged tumor control with ...

Trastuzumab botidotin is a HER2-targeted ADC composed of a cytotoxic drug (Duostatin-5, anti-microtubule agent) with ...

The move is intended to ensure faster operationalisation of auctioned mineral blocks and prevent delays that have often ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational ...

The newly formed Hightower Signature Wealth "widens the aperture for who we could acquire because we can probably do more ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK-pathway-driven cancers, today announced positive, updated efficacy and ...

XTR008 significantly improved PFS, ORR, and quality of life compared to octreotide LAR in SSTR-positive GEP-NETs. XTR008 therapy shows significant benefits in treating GEP-NETs, enhancing survival ...